Skip to main content
. 2022 Feb 3;327(11):1085–1087. doi: 10.1001/jama.2022.1393

Figure. Anti-Spike RBD Levels by Time Since COVID-19 Diagnosis.

Figure.

Anti–receptor-binding domain (RBD) levels did not differ by months since COVID-19 diagnosis (0.8% increase [95% CI, –2.4% to 4.2%] per month; P = .62). Data markers indicate individual anti-RBD titers; solid orange curve with shaded area, linear regression with 95% confidence range.